Abilify Asimtufii 720 mg
Abilify Asimtufii 720 mg is a medicine authorised by Swissmedic under authorisation number 69793. The authorisation holder is Lundbeck (Schweiz) AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 24 June 2025 and the authorisation is limited until 23 June 2030. ATC code N05AX12 places the medicine in the group Psycholeptics.
| Authorisation number | 69793 |
|---|---|
| Name | Abilify Asimtufii 720 mg |
| Full name | Abilify Asimtufii 720 mg, Depot-Injektionssuspension in einer Fertigspritze |
| Authorisation holder | Lundbeck (Schweiz) AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | N05AX12 |
| First authorisation | 24 June 2025 |
| Authorisation validity | 23 June 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Abilify Asimtufii 720 mg, Depot-Injektionssuspension in einer Fertigspritze | B | 24 June 2025 |
| 2 | Abilify Asimtufii 960 mg, Depot-Injektionssuspension in einer Fertigspritze | B | 24 June 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Fertigspritze(n) | N05AX12 | 01.05.0. | B |
| 2 | 1 | Fertigspritze(n) | N05AX12 | 01.05.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Abilify Asimtufii 720 mg authorised in Switzerland?
Yes. Abilify Asimtufii 720 mg is authorised by Swissmedic under authorisation number 69793, data as of 01 September 2026. The authorisation is limited until 23 June 2030.
Which dispensing category does Abilify Asimtufii 720 mg have?
Abilify Asimtufii 720 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Abilify Asimtufii 720 mg?
The authorisation holder is Lundbeck (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.